About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Holy Cross 9th Annual Winter Oncology Symposium
https://www.hconcologysymposium.com/
9th Annual Winter Oncology Symposium
Lung Cancers
Gastrointestinal Cancers
Gyn Cancers
Breast Cancers
Events
Therapeutic Strategies in HER2+ Breast Cancer - Pertuzumab, Neratinib and T-DM1 Therapy
By
Holy Cross 9th Annual Winter Oncology Symposium
FEATURING
Beverly Moy
April 23, 2019
1 Comment
Login to view comments.
Click here to Login
Featured Video
18:08
Novartis Oncology
Expert Discussion: What Is a Key Driver of HR+/HER2- mBC?
Feat.
D. Juric
Featured Video
20:49
Novartis Oncology
An Expert Discussion on the Overall Survival, Time to Chemotherapy, …
Feat.
A. Bardia
Breast Cancers
24:03
Holy Cross 9th Annual Winter Oncology Symposium
Early Stage Breast Cancer - Comparison of Trials of Genomic Assays -…
Feat.
R. L. Mahtani
14:23
Holy Cross 9th Annual Winter Oncology Symposium
Oncoplastic Reduction in Locally Advanced Breast Cancer
Feat.
J. Burgers
13:07
Holy Cross 9th Annual Winter Oncology Symposium
Panel Discussion on Breast Cancer: Promising Drugs and Future Treatm…
Feat.
E. Segota,
R. L. Mahtani,
J. Burgers,
M. Abu-Khalaf,
B. Moy
24:33
Holy Cross 9th Annual Winter Oncology Symposium
Therapeutic Strategies in HER2+ Breast Cancer - Pertuzumab, Neratini…
Feat.
B. Moy
12:05
Holy Cross 9th Annual Winter Oncology Symposium
Future Directions in the Targeting of HER2+ Breast Cancer: duration …
Feat.
B. Moy
12:44
Holy Cross 9th Annual Winter Oncology Symposium
Emerging Targets in ER Positive Breast Cancer: CDK4/6 inhibitors, Bc…
Feat.
M. Abu-Khalaf
10:12
Holy Cross 9th Annual Winter Oncology Symposium
Emerging Targets in HER-2 Negative, TNBC and HER-3 Positive Breast C…
Feat.
M. Abu-Khalaf
